United Therapeutics (UTHR) Short Interest Ratio & Short Volume $295.52 -4.64 (-1.55%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$294.36 -1.15 (-0.39%) As of 07/11/2025 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock United Therapeutics Short Interest DataUnited Therapeutics (UTHR) has a short interest of 75,600 shares, representing 0.19% of the float (the number of shares available for trading by the public). This marks a -95.30% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 444,965 shares to cover all short positions.Current Short Interest75,600 sharesPrevious Short Interest1,610,000 sharesChange Vs. Previous Month-95.30%Dollar Volume Sold Short$21.72 millionShort Interest Ratio0.3 Days to CoverLast Record DateJune 30, 2025Outstanding Shares45,110,000 sharesShort Percent of Float0.19%Today's Trading Volume300,699 sharesAverage Trading Volume444,965 sharesToday's Volume Vs. Average68% Short Selling United Therapeutics? Sign up to receive the latest short interest report for United Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartUTHR Short Interest Over TimeUTHR Days to Cover Over TimeUTHR Percentage of Float Shorted Over Time United Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/202575,600 shares $21.72 million -95.3%0.2%0.3 $287.35 6/15/20251,610,000 shares $456.19 million -14.4%3.7%2.9 $283.35 5/31/20251,880,000 shares $594.72 million -10.5%4.3%3.7 $316.34 5/15/20252,100,000 shares $638.23 million +6.6%4.8%4.1 $303.92 4/30/20251,970,000 shares $597.09 million +18.7%4.5%3.9 $303.09 4/15/20251,660,000 shares $472.80 million -2.9%3.8%3.4 $284.82 3/31/20251,710,000 shares $527.14 million -6.6%3.9%3.6 $308.27 3/15/20251,830,000 shares $562.25 million -25.6%4.2%4.1 $307.24 2/28/20252,460,000 shares $787.10 million +18.8%5.6%6.1 $319.96 2/15/20252,070,000 shares $767.10 million +3.0%4.7%5.8 $370.58 Get the Latest News and Ratings for UTHR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20252,010,000 shares $705.85 million +1.5%4.6%6.3 $351.17 1/15/20251,980,000 shares $716.05 million +3.1%4.5%6.2 $361.64 12/31/20241,920,000 shares $677.45 million -14.3%4.4%6.1 $352.84 12/15/20242,240,000 shares $810.45 million +7.7%5.1%6.8 $361.81 11/30/20242,080,000 shares $770.62 million -5.9%4.8%6.1 $370.49 11/15/20242,210,000 shares $802.78 million -3.9%5.0%6.1 $363.25 10/31/20242,300,000 shares $860.13 million +5.0%5.2%5.8 $373.97 10/15/20242,190,000 shares $787.46 million -2.2%5.0%5.3 $359.57 9/30/20242,240,000 shares $802.70 million -45.1%5.1%5.1 $358.35 9/15/20244,080,000 shares $1.38 billion -0.2%9.3%8.4 $339.12 8/31/20244,090,000 shares $1.49 billion -1.2%9.4%7.8 $363.55 8/15/20244,140,000 shares $1.34 billion +0.5%9.5%7.5 $323.08 7/31/20244,120,000 shares $1.29 billion -1.2%9.4%7.7 $313.29 7/15/20244,170,000 shares $1.36 billion -5.4%9.6%7.4 $327.26 6/30/20244,410,000 shares $1.40 billion +0.9%10.1%7.8 $318.55 6/15/20244,370,000 shares $1.26 billion +12.3%10.0%7.5 $288.06 5/31/20243,890,000 shares $1.07 billion +3.2%9.4%7.2 $275.13 5/15/20243,770,000 shares $1.03 billion -2.1%9.1%7.2 $272.69 4/30/20243,850,000 shares $902.17 million -10.9%9.4%7.4 $234.33 4/15/20244,320,000 shares $1.02 billion -11.7%10.0%9.4 $235.08 3/31/20244,890,000 shares $1.12 billion +154.7%11.3%11.3 $229.72 3/15/20241,920,000 shares $452.70 million +64.1%4.4%4.7 $235.78 2/29/20241,170,000 shares $264.00 million +0.9%2.7%3 $225.64 2/15/20241,160,000 shares $248.87 million +11.5%2.7%3.3 $214.54 1/31/20241,040,000 shares $223.37 million -11.9%N/A3.3 $214.78 1/15/20241,180,000 shares $258.48 million +7.3%N/A3.6 $219.05 12/31/20231,100,000 shares $241.88 million -15.4%N/A3.5 $219.89 12/15/20231,300,000 shares $320.39 million +14.0%N/A4.2 $246.45 11/30/20231,140,000 shares $273.60 million +0.9%N/A4.2 $240.00 11/15/20231,130,000 shares $259.06 million +4.6%N/A4.4 $229.26Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom (Ad)Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich. Click here to see the details on what could be the biggest tech story of this decade. 10/31/20231,080,000 shares $240.69 million +4.9%N/A3.6 $222.86 10/15/20231,030,000 shares $240.15 million +7.1%N/A3.4 $233.16 9/30/2023962,200 shares $217.33 million -13.3%N/A3.1 $225.87 9/15/20231,110,000 shares $244.47 million +1.8%N/A3.4 $220.24 8/31/20231,090,000 shares $244.55 million -42.3%N/A3.3 $224.36 8/15/20231,890,000 shares $445.53 million +94.6%N/A5.1 $235.73 7/31/2023971,100 shares $235.71 million -2.2%N/A2.7 $242.72 7/15/2023992,600 shares $230.28 million -8.1%N/A2.6 $232.00 6/30/20231,080,000 shares $238.41 million -5.3%N/A2.8 $220.75 6/15/20231,140,000 shares $261.73 million +9.6%N/A2.7 $229.59 5/31/20231,040,000 shares $218.13 million -22.4%N/A2.2 $209.74 5/15/20231,340,000 shares $287.30 million -8.2%N/A2.4 $214.40 4/30/20231,460,000 shares $335.99 million +6.6%N/A2.5 $230.13 4/15/20231,370,000 shares $313.35 million -3.5%N/A2.5 $228.72 3/31/20231,420,000 shares $318.02 million +6.0%N/A2.6 $223.96 3/15/20231,340,000 shares $291.45 million +0.8%N/A2.6 $217.50 2/28/20231,330,000 shares $327.23 million -5.0%N/A2.8 $246.04 2/15/20231,400,000 shares $354.70 million +11.1%3.1%3.6 $253.36 1/31/20231,260,000 shares $331.59 million -3.8%2.8%3.5 $263.17 1/15/20231,310,000 shares $341.96 million -1.5%2.9%3.4 $261.04 12/30/20221,330,000 shares $369.86 million +20.9%3.0%3.5 $278.09 12/15/20221,100,000 shares $303.44 million -17.9%2.5%3 $275.85 11/30/20221,340,000 shares $375.05 million -5.0%3.0%3.6 $279.89 11/15/20221,410,000 shares $365.36 million +6.8%3.2%3.8 $259.12 10/31/20221,320,000 shares $304.30 million -7.0%3.0%3.5 $230.53 10/15/20221,420,000 shares $307.34 million +6.8%3.2%3.9 $216.44 9/30/20221,330,000 shares $278.48 million +7.3%3.0%3.5 $209.38 9/15/20221,240,000 shares $273.59 million +41.4%2.8%3.1 $220.64 8/31/2022877,000 shares $198.75 million -18.0%2.0%2 $226.62 8/15/20221,070,000 shares $233.65 million +1.9%2.4%2.2 $218.36 7/31/20221,050,000 shares $242.62 million -11.0%2.4%2.1 $231.07 7/15/20221,180,000 shares $283.29 million -3.3%2.7%2.4 $240.08 6/30/20221,220,000 shares $287.48 million -6.9%2.8%2.5 $235.64 6/15/20221,310,000 shares $288.32 million -16.0%3.0%2.6 $220.09 5/31/20221,560,000 shares $359.33 million -12.4%3.5%3.2 $230.34 5/15/20221,780,000 shares $326.52 million +58.9%4.0%3.6 $183.44 4/30/20221,120,000 shares $198.87 million +8.7%2.5%2.5 $177.56 4/15/20221,030,000 shares $197.67 million -38.3%2.3%2.3 $191.91 3/31/20221,670,000 shares $299.61 million +67.0%3.8%3.5 $179.41 3/15/20221,000,000 shares $178.82 million -32.0%2.3%2.3 $178.82 2/28/20221,470,000 shares $244.31 million -8.1%3.3%3.4 $166.20 2/15/20221,600,000 shares $326.86 million -9.6%3.6%3.8 $204.29 1/31/20221,770,000 shares $357.31 million +37.2%4.0%4.5 $201.87 1/15/20221,290,000 shares $276.01 million +19.4%2.9%3.1 $213.96 12/31/20211,080,000 shares $233.37 million -21.7%2.5%2.7 $216.08 12/15/20211,380,000 shares $269.96 million -22.0%3.1%3.4 $195.62 11/30/20211,770,000 shares $335.42 million -5.9%4.0%4.6 $189.50 11/15/20211,880,000 shares $385.46 million -21.3%4.3%5.1 $205.03 10/29/20212,390,000 shares $455.92 million +18.3%5.4%6.5 $190.76 10/15/20212,020,000 shares $377.88 million -14.4%4.5%5.5 $187.07Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom (Ad)Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich. Click here to see the details on what could be the biggest tech story of this decade. 9/30/20212,360,000 shares $435.61 million -4.5%5.3%7 $184.58 9/15/20212,470,000 shares $504.55 million -23.8%5.6%7.6 $204.27 8/31/20213,240,000 shares $696.21 million +68.8%7.4%9.8 $214.88 8/13/20211,920,000 shares $389.03 million +18.5%4.4%5.4 $202.62 7/30/20211,620,000 shares $294.73 million -3.6%3.7%4.7 $181.93 7/15/20211,680,000 shares $309.44 million -4.6%3.8%5.5 $184.19 6/30/20211,760,000 shares $315.76 million No Change4.0%5.4 $179.41 6/15/20211,760,000 shares $314.07 million +0.6%4.0%4.6 $178.45 5/28/20211,750,000 shares $325.33 million -3.9%4.0%4.5 $185.90 5/14/20211,820,000 shares $352.66 million -9.9%4.2%4.8 $193.77 4/30/20212,020,000 shares $412.56 million No Change4.6%5.4 $204.24 4/15/20212,020,000 shares $409.62 million -13.7%4.7%5.5 $202.78 3/31/20212,340,000 shares $387.20 million +3.1%5.4%6 $165.47 3/15/20212,270,000 shares $362.07 million +18.2%5.2%6.7 $159.50 2/26/20211,920,000 shares $324.10 million +10.3%4.4%5.7 $168.80 2/12/20211,740,000 shares $294.98 million -1.1%4.0%5.4 $169.53 1/29/20211,760,000 shares $289.33 million +1.2%4.1%5.2 $164.39 1/15/20211,740,000 shares $291.03 million -7.9%4.0%4.4 $167.26 12/31/20201,890,000 shares $281.01 million -5.0%4.4%4.5 $148.68 12/15/20201,990,000 shares $284.85 million -3.9%4.6%4.9 $143.14 11/30/20202,070,000 shares $280.57 million -7.2%4.8%5.2 $135.54 10/30/20202,520,000 shares $328.23 million +12.5%5.8%6.8 $130.25 10/15/20202,240,000 shares $246.31 million +9.8%5.2%6.9 $109.96 9/30/20202,040,000 shares $206.04 million +10.9%4.7%7 $101.00 9/15/20201,840,000 shares $194.58 million No Change4.3%5.4 $105.75 8/31/20201,840,000 shares $196.81 million +10.8%4.3%4.7 $106.96 8/14/20201,660,000 shares $181.72 million -0.6%3.8%3.7 $109.47 7/31/20201,670,000 shares $186.15 million -13.5%3.9%3.2 $111.47 7/15/20201,930,000 shares $228.45 million -17.2%4.6%3.2 $118.37 UTHR Short Interest - Frequently Asked Questions What is United Therapeutics' current short interest? Short interest is the volume of United Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 75,600 shares of UTHR short. 0.19% of United Therapeutics' shares are currently sold short. Learn More on United Therapeutics' current short interest. Which institutional investors are shorting United Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of United Therapeutics: Jane Street Group LLC, Parallax Volatility Advisers L.P., Caption Management LLC, Nomura Holdings Inc., Walleye Trading LLC, Simplex Trading LLC, and Genus Capital Management Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for United Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.19% of United Therapeutics' floating shares are currently sold short. Is United Therapeutics' short interest increasing or decreasing? United Therapeutics saw a decline in short interest during the month of June. As of June 30th, there was short interest totaling 75,600 shares, a decline of 95.3% from the previous total of 1,610,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does United Therapeutics' short interest compare to its competitors? 0.19% of United Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to United Therapeutics: Alnylam Pharmaceuticals, Inc. (2.59%), Biogen Inc. (2.74%), Incyte Corporation (3.82%), Neurocrine Biosciences, Inc. (3.75%), Exelixis, Inc. (7.34%), BioMarin Pharmaceutical Inc. (3.43%), Exact Sciences Corporation (3.77%), Repligen Corporation (7.10%), Madrigal Pharmaceuticals, Inc. (22.78%), Halozyme Therapeutics, Inc. (8.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short United Therapeutics stock? Short selling UTHR is an investing strategy that aims to generate trading profit from United Therapeutics as its price is falling. UTHR shares are trading down $4.64 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against United Therapeutics? A short squeeze for United Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of UTHR, which in turn drives the price of the stock up even further. How often is United Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UTHR, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies ALNY Short Squeeze BIIB Short Squeeze INCY Short Squeeze NBIX Short Squeeze EXEL Short Squeeze BMRN Short Squeeze EXAS Short Squeeze RGEN Short Squeeze MDGL Short Squeeze HALO Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:UTHR) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s whole-government AI plans leakedThe New Elon Musk is officially stepping back from his day-to-day duties with DOGE. At least, that's the s...Altimetry | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UTHR Stock Alerts